AgNORs Predictive Value of Prognosis in Non-Hodgkin's Lymphoma: Comparison with Flow Cytometric Cell Cycle Analysis

References

• Rosenberg S. A. Non-Hodgkin's lymphoma-selection of treatment on the basis of histologic type. New England Journal of Medicine 1979; 301: 924–8
   PubMed Web of Science ®Google Scholar
• Steward W. P., Tood I. D. H., Harris M. A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin lymphoma. European Journal of Cancer and Clinical Oncology 1984; 20: 881–92
   PubMedGoogle Scholar
• Kaneko Y., Rowley I. D., Variakojis D., Haren I. M., Weshime Y., Daley K., Klushens L. F. Prognostic implicators at karyotype and morphology in patients with non-Hodgkin's lymphoma. International Journal of Cancer 1983; 32: 683–92
   PubMed Web of Science ®Google Scholar
• Koziner B., Little C., Passe S., Thaler T., Skaloft R., Straus D., Lee B., Clarkson B. Treatment of advanced diffuse histocyte lymphoma: an analysis of prognostic variables. Cancer 1982; 49: 1571–9
   PubMedGoogle Scholar
• Fisher R. I., Hubbard S. H., De Vitta V. T., Berard C. W., Wesky R., Cossman J., Young R. C. Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma. Blood 1981; 58: 45–51
   PubMed Web of Science ®Google Scholar
• Warnke R., Miller R., Grogan T., Pederson M., Dieley J., Levy R. Immunologic phenotype in 30 patients with diffuse large-cell lymphoma. New England Journal of Medicine 1980; 303: 293–300
   PubMed Web of Science ®Google Scholar
• Rehn S., Glimelius B., Strang P., Sundstrdm C., Tribukait B. Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematological Oncology 1990; 8: 1–12
   PubMed Web of Science ®Google Scholar
• Wooldrige T. N., Grierson H. L., Weisenburger D. D., Armitage J. O., Sagner W. G., Collins M. M., Pierson J. L., Pauza M. E., Fordyce R., Purtilo D. T. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma. Cancer Research 1988; 48: 6608–13
   PubMed Web of Science ®Google Scholar
• Macartney I. C., Camplejohn R. S., Moris R., Hollowood K., Clarke D., Timothy A. DNA flow cytometry of follicular non-Hodgkin's lymphoma. Journal of Clinical Pathology 1991; 44: 215–8
   PubMed Web of Science ®Google Scholar
• Cowan R. A., Harris M., Jones M., Crowther D. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations. British Journal of Cancer 1989; 60: 904–10
   PubMed Web of Science ®Google Scholar
• Cole C., Rowe D., Delbridge L., Philips J., Friedlander M. Comparison of image analysis and flow cytometric determination of cellular DNA content. Journal of Clinical Pathology 1991; 44: 147–51
   PubMed Web of Science ®Google Scholar
• Ploton D., Menger M., Jeannesson P., Himber G., Pigeon F., Adnet J. J. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochemical Journal 1986; 18: 5–14
   PubMedGoogle Scholar
• Crocher J., Nar P. Nucleolar organized regions in lymphomas. Journal of Pathology 1987; 151: 111–9
   PubMed Web of Science ®Google Scholar
• Lennert K. Malignant lymphomas other than Hodgkin's disease. Springer-Verlag, Berlin 1978
   Google Scholar
• Hedley D. W., Friedlander M. L., Taylor I. W., Rugg C. A., Musgrove E. A. Method of analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. The Journal of Histochemistry and Cytochemistry 1983; 31: 1333–5
   PubMed Web of Science ®Google Scholar
• Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. Journal of Cell Biology 1975; 66: 188–93
   PubMed Web of Science ®Google Scholar
• Egan M., Ramsden K., Crocher J. Diagnostic significance of mean numbers of nucleolar organiser regions in benign and malignant transitional tumors of nose. Histopathology 1988; 13: 579–81
   PubMed Web of Science ®Google Scholar
• Howat A. J., Giri D. D., Wright A. L., Underwood J. C. E. Silver-stained nucleoli and nucleolar organizer region counts are of no prognostic value in thick cutaneous malignant melanoma. Journal of Pathology 1988; 156: 227–32
   PubMed Web of Science ®Google Scholar
• Peto R., Pike M C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson E., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Number Cruncher Statistical System Reference Manual. version 5.01. Dr. Jerry L. Hintze, Kaysville 1987; 127–38
   Google Scholar
• Norman G. R., Streiner D. L. PDQ Statistics. B.C. Decker Inc., Toronto 1986; 115–31
   Google Scholar
• Petz B. Osnovne statistike metode za nematematiare. SNL., Zagreb 1986; 210–1
   Google Scholar
• Akerman M., Brandt L., Johnson A., Olsson H. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis. British Journal of Cancer 1987; 55: 219–23
   PubMed Web of Science ®Google Scholar
• Brittinger G., Battles H., Common H. Clinical and prognostic relevance of the Kiel classification in non-Hodgkin's lymphomas. Results of a prospective multi-center study by the Kiel Lymphoma Study Group. Hematological Oncology 1984; 2: 269–306, and other 45
   PubMedGoogle Scholar
• Crocker J., Macartney J. C., Smith P. J. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. Journal of Pathology 1988; 154: 151–6
   PubMed Web of Science ®Google Scholar
• Lehtinen T., Aine R., Lehtinen M., Kallioniemi O. L., Leino T., Hakala T., Leinikki P., Alavaikko M. Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non-Hodgkin lymphomas. Journal of Pathology 1989; 157: 27–36
   PubMed Web of Science ®Google Scholar